Answers are grounded in this paper and cite their sources.
This meta-analysis shows efficacy and safety of terlipressin in the treatment of hepatorenal syndrome. However, a significant number of responder patients relapsed after terlipressin withdrawal. Further studies are in progress to address the link between terlipressin and survival in hepatorenal syndrome patients.
No takes yet. Share an insight, caveat, or question.
Fabrizi et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: